Thermo Fisher Scientific Inc (TMO) Given Average Rating of “Buy” by Analysts

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) have been given a consensus recommendation of “Buy” by the fifteen ratings firms that are currently covering the company. Three equities research analysts have rated the stock with a hold recommendation, eleven have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $169.52.

Several brokerages recently issued reports on TMO. Zacks Investment Research upgraded Thermo Fisher Scientific from a “sell” rating to a “hold” rating in a research note on Wednesday, February 1st. Leerink Swann began coverage on Thermo Fisher Scientific in a research note on Thursday, November 10th. They set an “outperform” rating and a $175.00 price objective on the stock. Goldman Sachs Group, Inc. (The) restated a “conviction-buy” rating and set a $168.00 price objective (down from $170.00) on shares of Thermo Fisher Scientific in a research note on Monday, December 12th. Deutsche Bank AG restated a “buy” rating and set a $163.00 price objective on shares of Thermo Fisher Scientific in a research note on Wednesday, January 18th. Finally, Jefferies Group LLC reduced their price objective on Thermo Fisher Scientific from $163.00 to $160.00 and set a “hold” rating on the stock in a research note on Monday, January 23rd.

COPYRIGHT VIOLATION WARNING: “Thermo Fisher Scientific Inc (TMO) Given Average Rating of “Buy” by Analysts” was posted by sleekmoney and is owned by of sleekmoney. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be accessed at http://sleekmoney.com/thermo-fisher-scientific-inc-tmo-given-average-rating-of-buy-by-analysts/1655679.html.

Several hedge funds and other institutional investors have recently modified their holdings of TMO. Boston Private Wealth LLC raised its position in shares of Thermo Fisher Scientific by 1.6% in the second quarter. Boston Private Wealth LLC now owns 8,304 shares of the company’s stock worth $1,227,000 after buying an additional 129 shares during the period. BB&T Corp raised its position in shares of Thermo Fisher Scientific by 9.6% in the second quarter. BB&T Corp now owns 13,626 shares of the company’s stock worth $2,014,000 after buying an additional 1,191 shares during the period. Bank of Hawaii raised its position in shares of Thermo Fisher Scientific by 2.9% in the second quarter. Bank of Hawaii now owns 16,603 shares of the company’s stock worth $2,453,000 after buying an additional 463 shares during the period. Concert Wealth Management Inc. acquired a new position in shares of Thermo Fisher Scientific during the second quarter worth approximately $283,000. Finally, North Star Asset Management Inc. raised its position in shares of Thermo Fisher Scientific by 1.0% in the second quarter. North Star Asset Management Inc. now owns 45,792 shares of the company’s stock worth $6,766,000 after buying an additional 435 shares during the period. 87.69% of the stock is currently owned by institutional investors.

Thermo Fisher Scientific (NYSE:TMO) opened at 154.89 on Monday. Thermo Fisher Scientific has a 52 week low of $126.42 and a 52 week high of $160.68. The firm has a market capitalization of $61.12 billion, a PE ratio of 30.42 and a beta of 1.10. The firm has a 50-day moving average of $146.53 and a 200 day moving average of $149.73.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Tuesday, January 31st. The company reported $2.41 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.38 by $0.03. The company earned $4.95 billion during the quarter, compared to analysts’ expectations of $4.98 billion. Thermo Fisher Scientific had a return on equity of 15.41% and a net margin of 11.06%. The business’s revenue was up 6.5% on a year-over-year basis. During the same period in the prior year, the business posted $2.12 EPS. Analysts predict that Thermo Fisher Scientific will post $9.16 earnings per share for the current year.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/thermo-fisher-scientific-inc-tmo-given-average-rating-of-buy-by-analysts/1655679.html

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *